Research Profiles
Curated, compliance-reviewed stock profiles — each one thoroughly researched, vetted, and presented with full transparency so you can make informed decisions.
The Stock Sleuth
"Do the math..."NASDAQ: CMPS
Psychedelic Medicine · Clinical-Stage BiopharmaceuticalsThe most advanced psychedelic-medicine company in the world — two successful Phase 3 trials, an active rolling NDA at the FDA, and a White House Executive Order accelerating the runway to commercial launch. Wall Street's mean target implies ~167% upside; the high target is a potential 7x.
NASDAQ: SPCX
Space Launch & Satellite Internet · Newly PublicThe largest IPO in history — SpaceX launches ~85% of everything the world puts into orbit and runs Starlink, the only profitable satellite-internet network on Earth. The stock now trades below its $135 IPO at ~$113, while a wave of buy-equivalent Street initiations put the consensus near $244.
More Research
Additional buy recommendations and our historical track record of past stock picks.